BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 21, 2003
View Archived Issues
GTx Financing Pulls Down $20M To Advance Men's Health Drugs
Read More
MultiCell Pushes Liver Proteins With $18M XenoTech Contract
Read More
Neurochem Files For U.S. IPO As Well As Follow-On In Canada
Read More
Other News To Note
Read More
Rinat Secures $40M In Series B Round To Advance Neuro Drugs
Rinat Neuroscience Corp. returned to the private financing well and brought in $40 million through a Series B round that will fund drug development for the next several years. (BioWorld Today)
Read More
Nucleonics Licenses RNAi Rights From Wyeth For 5 Percent Stake
Read More